Martin Samuel Bates
SEC insider (Form 3/4/5 filer). CIK 0001709024. SVP AND CFO at Celldex Therapeutics, Inc. (CLDX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in HAMPTON, NJ.
Companies Martin Samuel Bates has filed insider reports for
- Celldex Therapeutics, Inc. (CLDX): Officer, SVP AND CFO
Martin Samuel Bates
CIK: 0001709024
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLDX
Celldex Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
93K shares- - Jan 2, 2026CLDX
Celldex Therapeutics, Inc.
ExerciseDirect4.8K shares at avg. $10.38$50K - Jun 5, 2025CLDX
Celldex Therapeutics, Inc.
AwardDirectIncentive Stock Option (right to buy)
81K shares-
1-3 of 3 transactions